Skip to main content

EraGen Expands Licensing and Distribution Agreement with Luminex

NEW YORK, April 26 (GenomeWeb News) - EraGen Biosciences has signed an expanded licensing and distribution agreement with Luminex, the Madison, Wis.-based firm said today.


Under the terms of the expanded agreement, EraGen has obtained the rights to distribute and sell Luminex 100 systems and kits that include EraGen's non-standard nucleic acid bases for selected in vitro diagnostic applications, EragGen said.


Financial terms of the agreement were not disclosed.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.